
Breast imaging software developer Volpara Solutions has appointed Ann Custin to its board as an independent, nonexecutive director, effective September 1.
Custin most recently held an executive role at Siemens Healthineers, where she served as chief financial officer and board director of Siemens Medical Solutions, Volpara said. She has also been chief operating and financial officer of Scient'x, as well as president and CEO of USA Draeger Medical Systems.
Custin replaces Dr. Monica Saini, who has retired as a nonexecutive director on the Volpara board. However, Saini will continue to provide input into future product development as a user of Volpara products in her private breast cancer screening practice, according to the vendor.












![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)





